Dental Pain – Pipeline Review, H2 2017

Table of ContentsList of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Dental Pain – Overview
Dental Pain – Therapeutics Development
Pipeline Overview
Pipeline by Companies
Products under Development by Companies
Dental Pain – Therapeutics Assessment
Assessment by Target
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Dental Pain – Companies Involved in Therapeutics Development
Laboratorios Del Dr Esteve SA
Pacira Pharmaceuticals Inc
Teva Pharmaceutical Industries Ltd
Dental Pain – Drug Profiles
(celecoxib + tramadol hydrochloride) – Drug Profile
Product Description
Mechanism Of Action
R&D Progress
A-100 – Drug Profile
Product Description
Mechanism Of Action
R&D Progress
AFAP-3 – Drug Profile
Product Description
Mechanism Of Action
R&D Progress
bupivacaine ER – Drug Profile
Product Description
Mechanism Of Action
R&D Progress
funapide – Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Dental Pain – Dormant Projects
Dental Pain – Discontinued Products
Dental Pain – Product Development Milestones
Featured News & Press Releases
Jun 21, 2012: Iroko Pharma Announces Phase III Study Results Of Diclofenac
Nov 04, 2011: Phase II Results For Nano-formulated NSAIDs Under Development At Iroko Pharmaceuticals To Be Reported At ACR Meeting
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer

Powered by WPeMatico